| pubmed-article:11952431 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11952431 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:11952431 | lifeskim:mentions | umls-concept:C0021925 | lld:lifeskim |
| pubmed-article:11952431 | lifeskim:mentions | umls-concept:C0246631 | lld:lifeskim |
| pubmed-article:11952431 | lifeskim:mentions | umls-concept:C0234422 | lld:lifeskim |
| pubmed-article:11952431 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:11952431 | lifeskim:mentions | umls-concept:C1708050 | lld:lifeskim |
| pubmed-article:11952431 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:11952431 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11952431 | pubmed:dateCreated | 2002-4-15 | lld:pubmed |
| pubmed-article:11952431 | pubmed:abstractText | Awake fiberoptic intubation is the standard of care for difficult airway management. Quality and success of this technique depend on the experience of the intubating physician and the proper preparation of the patient. The aim of this study was to compare remifentanil (R) as single agent to the combination of fentanyl (F) and midazolam (M), which have been the drugs for analgesia and sedation for this procedure. | lld:pubmed |
| pubmed-article:11952431 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11952431 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11952431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11952431 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11952431 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11952431 | pubmed:issn | 0001-5172 | lld:pubmed |
| pubmed-article:11952431 | pubmed:author | pubmed-author:GombotzHH | lld:pubmed |
| pubmed-article:11952431 | pubmed:author | pubmed-author:PühringerFF | lld:pubmed |
| pubmed-article:11952431 | pubmed:author | pubmed-author:EggerPP | lld:pubmed |
| pubmed-article:11952431 | pubmed:author | pubmed-author:ObwegeserJJ | lld:pubmed |
| pubmed-article:11952431 | pubmed:author | pubmed-author:LöckingerAA | lld:pubmed |
| pubmed-article:11952431 | pubmed:author | pubmed-author:PuchnerWW | lld:pubmed |
| pubmed-article:11952431 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11952431 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:11952431 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11952431 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11952431 | pubmed:pagination | 350-4 | lld:pubmed |
| pubmed-article:11952431 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:meshHeading | pubmed-meshheading:11952431... | lld:pubmed |
| pubmed-article:11952431 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11952431 | pubmed:articleTitle | Evaluation of remifentanil as single drug for awake fiberoptic intubation. | lld:pubmed |
| pubmed-article:11952431 | pubmed:affiliation | Department of Anesthesia and Intensive Care Medicine, General Hospital of Linz, Austria. wolfgang.puchner@akh.linz.at | lld:pubmed |
| pubmed-article:11952431 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11952431 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11952431 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11952431 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11952431 | lld:pubmed |
